Navigation Links
Synutra Issues Statement Regarding Market Rumors on Revocation of its Production Certification
Date:2/20/2009

QINGDAO, China and ROCKVILLE, Md., Feb. 20 /PRNewswire-Asia/ -- Synutra International, Inc. (Nasdaq: SYUT, "Synutra"), a leading infant formula company in China, and a producer, marketer and seller of nutritional products for infants, children and adults, today issued a statement explaining the inclusion of certain production permit numbers in a published list of revoked production permit numbers by China General Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ). The Company had recently filed an application with AQSIQ for the revocation of obsolete production permits due to the dissolution of one of its operating subsidiaries, Qingdao Shengyuan Dairy Co., Ltd. The Company clarifies that all products under the old production permits are being made, distributed and sold by successor company Shengyuan Nutrition Food Co., Ltd. under the new production permit number QS370005020047, which is effective until December 21, 2010.

Synutra President and Chief Operating Officer Weiguo Zhang said, "Technical updates to our production certification are routine business activities and market speculations that we are closing our facilities are groundless and irresponsible. We operate within all applicable laws and regulations within China and in the United States. We are committed to providing our Chinese consumers the highest quality and safest products possible and we strive to continually improve shareholder value."

About Synutra International, Inc.

Synutra operates nine subsidiaries developing, producing, distributing and selling dairy-based nutritional products across the People's Republic of China. It offers its products for infants, children, adults, pregnant women and nursing mothers under the "Sheng Yuan" or "Synutra" master brand and several sub-brands, including "Super," "U-Smart" and "Minshan." The Group's extensive sales network covers 29 provinces and provincial-level municipalities in China, and comprises over 420 distributors and over 1,000 sub-distributors who sell Synutra's products in nearly 63,400 retail outlets.

The information contained herein includes statements, estimates, projections, guidance or outlook that constitute "forward-looking" statements as defined under U.S. federal securities laws. Generally the words "believe," "expect," "intend," "estimate," "anticipate," "plan," "project," "will" and similar expressions, identify forward-looking statements, which generally are not historical in nature. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

    For more information, please contact:

     Weiguo Zhang of Synutra, Inc.
     Tel:      +1-301-840-3888
     Email:    wzhang@synutra.com
     Web site:http://www.synutra.com

     Delia Cannan of Taylor Rafferty
     Tel:   +1-212-889-4350
     Email: synutra@taylor-rafferty.com

'/>"/>
SOURCE Synutra International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Synutra Provides Progress Update on Recall and Reports Results for the Second Quarter Ended September 30, 2008
2. Synutra International, Inc. Amends August 2005 Current Report on Form 8-K and Annual Report on Form 10-K for the Fiscal Year Ended March 31, 2007
3. Nasdaq Informs Synutra that the Companys Filing Delinquency has been Cured
4. The Ensign Group, Inc. Reports Fourth Quarter 2008 Earnings of $0.38 per Share; Issues 2009 Guidance
5. CVS Caremark Issues Statement on Settlement Concerning Disposal of Patient Information at its Retail Stores
6. Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers: JNJ, ABT, LLY, PFE, NVS, GSK
7. Teens with cancer present unique psychological issues
8. Special Olympics Issues Report on the Impact of Special Olympics Healthy Athletes Initiative to show Need for Reauthorization of the Special Olympics Sport and Empowerment Act of 2004
9. Ther-Rx Corporation Issues Voluntary Nationwide Recall of Prescription Prenatal and Iron Supplements to Wholesale Level
10. ETHEX Corporation Issues Voluntary Nationwide Recall of Prescription Prenatal and Iron Supplements to Wholesale Level
11. ETHEX Corporation Issues Voluntary Nationwide Recall
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Prior Lake MN (PRWEB) , ... February 24, ... ... the launch of its newly designed TaskMate Go. Core benefits and advantages built ... grain finish and a stylish, functional look and feel. Ability to gain the ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis ... University of Pittsburgh points to eight genes that may explain why susceptibility to one ... the results of a study published today in the journal npj Schizophrenia. , ...
(Date:2/24/2017)... ... February 24, 2017 , ... With ... is so critically important that we all are aware of our options and ... is proud to announce the launch of its newest edition of "Vision and ...
(Date:2/24/2017)... ... February 24, 2017 , ... The California State University Institute ... faculty engaged in or interested in palliative care education and research. The Symposium, ... in North County San Diego on Sept. 28 and 29, 2017, on the campus ...
(Date:2/24/2017)... ... ... The Radiology Business Management Association will select the 2017 ... Building Better Radiology Marketing Programs conference, held this year from March 5 to ... are given out in five categories. They are:, ,     Patient Marketing, ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Research and Markets has announced the addition of ... to their offering. ... latest research Hemophilia Drugs Price Analysis and Strategies - 2016, provides drug ... answers the following questions: What are the ... positioned in the Global Hemophilia market? What are the ...
(Date:2/24/2017)... -- Physician General Dr. Rachel Levine and ... Smith commended South Central EMS today for their ... a life-saving overdose reversal drug. The recognition event also ... overdose survivor who was saved due to the administration ... part of fighting the opioid epidemic is making sure ...
(Date:2/24/2017)... HILL, N.C. , Feb. 24, 2017 /PRNewswire/ ... are exploring ways to increase their self-service capabilities ... Health Care Providers (HCPs). New research ... many pharma organizations have developed self-service website portals ... electronically.  This is just one of many findings ...
Breaking Medicine Technology: